Cargando…
SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
Background: While diabetes mellitus from growth hormone related insulin resistance is not uncommon in GH secreting tumors, initial presentation with diabetic ketoacidosis is rare. Clinical Case: 31 YO male with no significant past medical history presented with c/o fatigue, 40 lb weight loss, polyur...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207508/ http://dx.doi.org/10.1210/jendso/bvaa046.1077 |
_version_ | 1783530621792944128 |
---|---|
author | Gundluru, Rajani Verma, Ritika Regunath, Hariharan Gardner, Michael J Huynh, Kiet |
author_facet | Gundluru, Rajani Verma, Ritika Regunath, Hariharan Gardner, Michael J Huynh, Kiet |
author_sort | Gundluru, Rajani |
collection | PubMed |
description | Background: While diabetes mellitus from growth hormone related insulin resistance is not uncommon in GH secreting tumors, initial presentation with diabetic ketoacidosis is rare. Clinical Case: 31 YO male with no significant past medical history presented with c/o fatigue, 40 lb weight loss, polyuria, polydipsia. Clinical features of acromegaly with frontal bossing, protruding jaw, large hands and feet, thick spade like fingers, hammer toes, high arches and thickened fat pads on both feet were noted. Initial labs were consistent with DKA with anion of 31 mmol/L (0-20), blood glucose 241 mg/dl, bicarb 12 mmol/L (22-29), serum betahydroxy butyrate > 8 mmol/L (0-0.29), urine positive for glucose, ketones, protein. Patient was initially treated with IV insulin per DKA protocol, transitioned to subcutaneous insulin. MRI brain showed 2.1x1.3x2.1 cm pituitary macro adenoma. Labs showed elevated IGF1 LC/MS, S 1094 ng/ml (54-310), IGFBP3 14 mcg/ml (3.5-7), Z score IGF MS Mayo > 3 (-2 to +2), normal FSH 7.1 m unit/ml (1.5-12.4), normal LH 3.4 m unit/ml (1.7-8.6), normal prolactin 6 ng/ml (4-15), normal ACTH 10 pg/ml, cortisol 13.4 mcg/dl, low total testosterone 48.2 ng/dl (193-836), normal free testosterone 7.92 ng/dl (4.85-19), normal TSH 1.55 mc unit/ml (0.27-4.2) and free T4 1.17 ng/dl (0.93-1.7). The patient was discharged home on 120+ units of total daily dose of insulin, after initial hospital admission. He underwent trans sphenoidal resection of pituitary macro adenoma one month after his initial presentation. Surgical pathology confirmed growth hormone producing adenoma. He was successfully weaned off from insulin in one month following surgery. Conclusion: DKA is an unusual initial presentation of growth hormone producing tumors. As more cases are being reported it is important to be vigilant to look for DKA presentation in these patients and adjust/wean patients insulin once the growth hormone producing tumor is treated either with surgery or medications. |
format | Online Article Text |
id | pubmed-7207508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72075082020-05-13 SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation Gundluru, Rajani Verma, Ritika Regunath, Hariharan Gardner, Michael J Huynh, Kiet J Endocr Soc Neuroendocrinology and Pituitary Background: While diabetes mellitus from growth hormone related insulin resistance is not uncommon in GH secreting tumors, initial presentation with diabetic ketoacidosis is rare. Clinical Case: 31 YO male with no significant past medical history presented with c/o fatigue, 40 lb weight loss, polyuria, polydipsia. Clinical features of acromegaly with frontal bossing, protruding jaw, large hands and feet, thick spade like fingers, hammer toes, high arches and thickened fat pads on both feet were noted. Initial labs were consistent with DKA with anion of 31 mmol/L (0-20), blood glucose 241 mg/dl, bicarb 12 mmol/L (22-29), serum betahydroxy butyrate > 8 mmol/L (0-0.29), urine positive for glucose, ketones, protein. Patient was initially treated with IV insulin per DKA protocol, transitioned to subcutaneous insulin. MRI brain showed 2.1x1.3x2.1 cm pituitary macro adenoma. Labs showed elevated IGF1 LC/MS, S 1094 ng/ml (54-310), IGFBP3 14 mcg/ml (3.5-7), Z score IGF MS Mayo > 3 (-2 to +2), normal FSH 7.1 m unit/ml (1.5-12.4), normal LH 3.4 m unit/ml (1.7-8.6), normal prolactin 6 ng/ml (4-15), normal ACTH 10 pg/ml, cortisol 13.4 mcg/dl, low total testosterone 48.2 ng/dl (193-836), normal free testosterone 7.92 ng/dl (4.85-19), normal TSH 1.55 mc unit/ml (0.27-4.2) and free T4 1.17 ng/dl (0.93-1.7). The patient was discharged home on 120+ units of total daily dose of insulin, after initial hospital admission. He underwent trans sphenoidal resection of pituitary macro adenoma one month after his initial presentation. Surgical pathology confirmed growth hormone producing adenoma. He was successfully weaned off from insulin in one month following surgery. Conclusion: DKA is an unusual initial presentation of growth hormone producing tumors. As more cases are being reported it is important to be vigilant to look for DKA presentation in these patients and adjust/wean patients insulin once the growth hormone producing tumor is treated either with surgery or medications. Oxford University Press 2020-05-08 /pmc/articles/PMC7207508/ http://dx.doi.org/10.1210/jendso/bvaa046.1077 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Neuroendocrinology and Pituitary Gundluru, Rajani Verma, Ritika Regunath, Hariharan Gardner, Michael J Huynh, Kiet SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation |
title | SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation |
title_full | SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation |
title_fullStr | SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation |
title_full_unstemmed | SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation |
title_short | SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation |
title_sort | sat-251 new diagnosis of acromegaly with dka as initial presentation |
topic | Neuroendocrinology and Pituitary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207508/ http://dx.doi.org/10.1210/jendso/bvaa046.1077 |
work_keys_str_mv | AT gundlururajani sat251newdiagnosisofacromegalywithdkaasinitialpresentation AT vermaritika sat251newdiagnosisofacromegalywithdkaasinitialpresentation AT regunathhariharan sat251newdiagnosisofacromegalywithdkaasinitialpresentation AT gardnermichaelj sat251newdiagnosisofacromegalywithdkaasinitialpresentation AT huynhkiet sat251newdiagnosisofacromegalywithdkaasinitialpresentation |